newsfilter
← Latest News
Business Wire·

Niagen Bioscience Announces Participation in Upcoming Investor Conferences

  • Niagen Bioscience, Inc. (NASDAQ: NAGE) announced senior leadership participation in four upcoming investor conferences.
  • Rob Fried (CEO) & Ozan Pamir (CFO) will attend the A.G.P. Virtual Consumer Showcase on November 11-12, 2026, featuring a fireside chat on November 12.
  • Rob Fried & Ozan Pamir will present at the Southwest IDEAS Investor Conference in Irving, Texas, on November 18-19, 2026, including a presentation on November 19.
  • Rob Fried will attend the 15th Annual ROTH Deer Valley Event in Park City, Utah, from December 9-12, 2026, for one-on-one meetings.
  • Ozan Pamir will attend the StoneX 15th Annual Discovery Conference in New York, New York, on December 10, 2026, for one-on-one meetings.
  • The company offers Niagen (patented nicotinamide riboside) as a clinically tested NAD+ booster for consumer supplements, including Tru Niagen, & pharmaceutical-grade IV injectables via Niagen Plus.
  • Subsidiary NAD Pharmaceuticals Corp. is researching NB4168, a small molecule therapy for accelerated aging & rare genetic diseases.
  • Investors can schedule one-on-one meetings by contacting their conference representative or emailing Niagen@KCSA.com.